May 08, 2019 - Five drug/biotech stocks are scheduled to release their first-quarter results on May 9. Let's take a look at how these companies are poised ahead of their earnings release.
May 08, 2019 - Array BioPharma's (ARRY) top and bottom lines beat estimates in the third quarter of fiscal 2019. Momentum in uptake of Braftovi-Mektovi combination therapy continues.
May 07, 2019 - The focus will be on Nektar Therapeutics' (NKTR) pipeline progress when the company reports first-quarter results.
May 06, 2019 - The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo
May 06, 2019 - The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins
May 05, 2019 - A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.
May 03, 2019 - Top Stock Reports for Pfizer, Intel & HCA Healthcare
May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
May 03, 2019 - The index traversed a mixed week, buoyed by encouraging earnings numbers and dragged lower by comments from the Fed Chair.
May 02, 2019 - Exelixis's (EXEL) earnings and revenues beat expectations in the first quarter on strong sales of Cabometyx.